Page last updated: 2024-11-01
nimodipine and Delirium of Mixed Origin
nimodipine has been researched along with Delirium of Mixed Origin in 1 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|
| "Nimodipine is a clinical commonly used calcium antagonistscan lowering the apoptosis rate of hippocampal neuron to reduce the incidence of postoperative cognitive dysfunction (POCD)." | 6.84 | Effects of nimodipine on postoperative delirium in elderly under general anesthesia: A prospective, randomized, controlled clinical trial. ( Guo, YY; Huo, SP; Li, YN; Wang, L; Wang, QJ; Yin, CP; Zhang, Q, 2017) |
| "Nimodipine is a clinical commonly used calcium antagonistscan lowering the apoptosis rate of hippocampal neuron to reduce the incidence of postoperative cognitive dysfunction (POCD)." | 2.84 | Effects of nimodipine on postoperative delirium in elderly under general anesthesia: A prospective, randomized, controlled clinical trial. ( Guo, YY; Huo, SP; Li, YN; Wang, L; Wang, QJ; Yin, CP; Zhang, Q, 2017) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Li, YN | 1 |
| Zhang, Q | 1 |
| Yin, CP | 1 |
| Guo, YY | 1 |
| Huo, SP | 1 |
| Wang, L | 1 |
| Wang, QJ | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| Anesthetic Method and Cerebral Outcomes: A Prospective Randomized Controlled Trial.[NCT03696719] | | 140 participants (Anticipated) | Interventional | 2018-11-01 | Active, not recruiting |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Trials
1 trial available for nimodipine and Delirium of Mixed Origin